<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">Pseudotumor Cerebri</z:e> (PTC) is an uncommon disorder whose etiology is largely unknown, although its association with steroid withdrawal, <z:e sem="disease" ids="C0342951" disease_type="Disease or Syndrome" abbrv="">hypervitaminosis</z:e> A, and the use of the <z:chebi fb="9" ids="27902">tetracycline</z:chebi> group of drugs has been well documented </plain></SENT>
<SENT sid="1" pm="."><plain>We report here a case in which a patient on <z:hpo ids='HP_0011010'>chronic</z:hpo> divalproex therapy for a <z:hpo ids='HP_0001250'>seizure</z:hpo> disorder developed PTC </plain></SENT>
<SENT sid="2" pm="."><plain>Changing his <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> medication from divalproate to topiramate effected a remission of PTC symptoms while maintaining his <z:hpo ids='HP_0001250'>seizure</z:hpo>-free status </plain></SENT>
<SENT sid="3" pm="."><plain>It is recommended that physicians treating <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, vascular <z:hpo ids='HP_0002315'>headaches</z:hpo>, or <z:e sem="disease" ids="C0525045" disease_type="Mental or Behavioral Dysfunction" abbrv="">mood disorders</z:e> with divalproate consider the diagnosis of PTC when their patients complain of new <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0002315'>headaches</z:hpo> or an increase in frequency or severity of existing <z:hpo ids='HP_0002315'>headaches</z:hpo>--especially those associated with a visual disturbance--to prevent permanent <z:hpo ids='HP_0000572'>visual loss</z:hpo> </plain></SENT>
</text></document>